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Barely Scratching the Surface
I
tchingorpruritusisanunpleasantsen-
sationthatevokesthedesireorreﬂexto
scratch.Itchinginpeoplewithdiabetes
forthemostpartsuggestsaskincondition
such as psoriasis, eczema, sunburn, ath-
lete’s foot, hidradenitis suppurativa, pru-
ritus vulvae from monilial infections,
xerosis and diabetic eczema, necrobiosis
diabeticorum, allergies to medications,
drug eruptions, and many other condi-
tions. Most are inﬂammatory disorders.
In addition, there are generalized medical
conditions that need to be excluded such
asobstructivejaundice(bilirubinisaskin
irritant at high concentrations), polycy-
themiathatcancausegeneralizeditching,
myxedema,hypoparathyroidism,uremia,
iron deﬁciency anemia, and malignancy
or systemic internal cancers such as lym-
phomaorHodgkin’sdisease(1).Whenall
have been considered and excluded, the
question that needs to be answered is,
Does the itching derive from a peripheral
or a central mechanism?
Sensations associated with
scratching
Pain and itch have very different behav-
ioral response patterns. Pain evokes a
withdrawal reﬂex that leads to retraction
and is therefore a reaction trying to pro-
tect an endangered part of the body. Itch
creates a scratch reﬂex that draws one to
the affected skin site (2). It has been hy-
pothesized that motivational aspects of
scratching include the frontal brain areas
of reward and decision making. These as-
pects might therefore contribute to the
compulsive nature of itch and scratching
(2).Itisclear,therefore,thatitchingisnot
skin-deep.
Unmyelinated nerve ﬁbers for itch
and pain both originate in the skin; how-
ever, information for them is conveyed
centrallyintwodistinctsystemsthatboth
usethesameperipheralnervebundleand
spinothalamic tract (3). It is surprising,
then,thatnoonehasreportedonitchasa
symptom of neuropathy. In this issue of
Diabetes Care, Yamaoka et al. (4) report
on truncal itching as being a symptom of
diabetic neuropathy. A large-scale survey
of 2,656 outpatients with diabetes and
499 patients without diabetes was per-
formed. The prevalence of truncal pruri-
tusofunknownorigin(TPUO)indiabetic
subjectswassigniﬁcantlyhigherthanthat
in age-matched nondiabetic subjects
(11.3 vs. 2.9%; P  0.0001). The preva-
lence of other forms of pruritus was not
different between the two groups. Multi-
ple logistic regression analysis revealed
that abnormal sensation and deep tendon
areﬂexia were risk factors for TPUO inde-
pendent of age, sex, duration of diabetes,
and A1C. Only TPUO related to objective
measures of neuropathy; the other ﬁve
categories of itching, such as head and
neckpruritusofunknownorigin,legpru-
ritus of unknown origin, pruritus caused
by dermatitis, and pruritus due to ath-
lete’s foot, did not relate the presence or
absence of neuropathy. More impor-
tantly, TPUO was found to correlate with
symptoms of neuropathy, loss of deep
tendon reﬂexes, and orthostatic hypoten-
sion. The authors speculate that this is,
therefore, a dysfunction of the autonomic
nervous system, but there are no mea-
sures of skin blood ﬂow (5), sudorimetry,
or small nerve ﬁber function (6,7,8) that
might have solidiﬁed this speculation.
Theauthorsfurtherpostulatethatpruritis
may be due to an increased mast cell
number and histamine content, which
has been reported in experimental dry
skin in mice (9). A second possibility is
that the sensory C-ﬁber damage by ddia-
betic polyneuropathy causes pruritus di-
rectly. Superﬁcial skin pain is considered
to be caused by abnormal ﬁring of the
pain nerve ﬁber in diabetic polyneurop-
athy patients (10). Similarly, abnormal
ﬁring of the nerve ﬁber of pruritus may
induce TPUO. In fact, hyperplasia of the
C-ﬁber in epidermis has been reported in
dermatitis with strong pruritus (11). The
unmyelinated C-ﬁber that transmits pru-
ritus is a similar ﬁber to the sympathetic
nerve ending in the skin. So, a signiﬁcant
association between TPUO and ortho-
static intolerance seems to be reasonable.
Both of the two etiological factors, dry
skin due to sudomotor hypofunction and
direct nerve ﬁber damage by diabetic
polyneuropathy, might be involved in
TPUO. To know the accurate etiology of
TPUO, a skin biopsy and nerve ﬁber
staining with anti-protein gene product
9.5 antibody in patients with TPUO may
have helped (12). From the point of view
of mechanistic aspects of itching, this re-
port is barely scratching the surface of
itching; hereafter, we will probe further
than skin-deep. Itch can originate in the
peripheral nervous system (dermal or
neuropathic) or in the central nervous
system (neuropathic, neurogenic, or psy-
chogenic) (13).
Dermal/pruritoceptive
Itch originating in the skin is considered
pruritoceptive and can be induced by a
variety of stimuli, including mechanical,
chemical, thermal, and electrical stimula-
tion. The primary afferent neurons re-
sponsible for histamine-induced itch are
unmyelinatedC-ﬁbers.Twomajorclasses
of human C-ﬁber nociceptors exist:
mechano-responsive nociceptors and
mechano-insensitive nociceptors.
Mechano-responsive nociceptors have
been shown in studies to respond to
mostlypain,whereasmechano-insensitivere-
ceptorsrespondmostlytoitchinducedby
histamine. Mechanically induced itch
without a ﬂare reaction does not involve
histamine; therefore, it is possible that
pruritoceptive nerve ﬁbers have different
classes of ﬁbers (2).
Itch receptors are only found in the
epidermis and the epidermal/dermal
transition layers. Individual itch powder
spicules (mucuna pruriens) cause maxi-
mal sensitivity when injected into the
basal cell layer or the innermost layer of
the epidermis. Surgical removal of those
skin layers removes the ability for a pa-
tient to perceive itch. Itch is never felt in
muscle, joints, or inner organs, which
shows that deep tissue does not contain
an itch-signaling apparatus (14).
Sensitivity to pruritic stimuli is not
evenly distributed across the skin and has
a random spot distribution with similar
densities to that of pain. The same sub-
stances that elicit itch upon intracutane-
ous injection (injection within the skin)
elicit only pain when injected subcutane-
ously (beneath the skin). Itch is readily
abolished in skin areas treated with noci-
ceptor excitotoxin capsaicin but remains
unchanged in skin areas that were rendered
insensitive to touch by pretreatment with sa-
ponins, an anti-inﬂammatory agent. Al-
though experimentally induced itch can
still be perceived under a complete A-ﬁ-
ber conduction block, it is signiﬁcantly
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diated by A- and C nociceptors located
in the uppermost layer of the skin (15).
Probing the beyond–skin-deep
perception
Neuropathic itch can originate at any
point along the afferent pathway as a re-
sult of damage to the nervous system, in-
cluding diseases or disorders in the
central nervous system or peripheral ner-
vous system (14). Examples of neuro-
pathic itch in origin are notalgia
paresthetica, brachioradial pruritis, brain
tumors, multiple sclerosis, peripheral
neuropathy, and nerve irritation (16).
Neurogenic
Neurogenic itch, which is itch induced
centrally but with no neural damage, is
often associated with increased accumu-
lation of endogenous opioids and possi-
bly synthetic opioids (14).
Psychogenic
Itch is also associated with some symp-
toms of psychiatric disorders such as
tactile hallucinations, delusions of parasi-
tosis, or obsessive-compulsive disorders
(as in OCD-related neurotic scratching)
(14).Thus,attributingitchtoaperipheral
neuropathy requires careful exclusion of
central causation.
Interactions between itch and pain:
pain inhibits itch
Counter-irritation has often been used to
decrease pain perception. It is often used
clinically, e.g., the application of capsa-
icin that induces pain only to desensitize
andrelieveit.However,itappearsthatthe
sensation of itch can be reduced by many
painful sensations. Ward et al. (17) re-
portedtheeffectsofnoxiousandnonnox-
ious counter stimuli, such as heat,
physical vibration, or chemical stimula-
tion on skin, were studied in healthy
adults after they had experimentally in-
duced itch (transdermal iontophoresis of
histamine) and pain (with topical mus-
tard oil) in their skin. They found that
when they induced nonnoxious counter
stimuli, the reduction of pain and itch
only lasted for up to 20 s. However, when
they induced noxious counter stimuli,
there was a signiﬁcant inhibition of itch
for an extended period of time but no in-
hibition of pain. In addition, it was found
that brief noxious stimuli created an anti-
itch state for more than 30 min. These
ﬁndingsshowthatitchisnotasubliminal
form of pain and that noxious counter-
stimulus is likely to act through a central
mechanism instead of a peripheral one
(17). Thus, noxious heat and scratching
have an inhibitory effect on itch (18), but
this needs to be demonstrated in diabetic
polyneuropathy.
Mediators of itch
There is a long prodromal period of dia-
betic polyneuropathy in which there are
increased levels of inﬂammatory cyto-
kines (5). Inﬂammatory mediators, such
as bradykinin, serotonin (5-HT), and
prostaglandins, that are released during a
painful or pruritic inﬂammatory condi-
tion not only activate pruriceptors but
also cause acute sensitization of nocicep-
tors. In addition, expression of nerve
growth factors (NGFs) can cause struc-
tural changes in nociceptors, such as
sprouting. NGF is high in injured or in-
ﬂamed tissue. Increased NGF is also
found in atopic dermatitis, a hereditary
and noncontagious skin disease with
chronic inﬂammation (19). NGF is
known to upregulate neuropeptides, es-
pecially substance P. Substance P has
been found to have an important role in
inducing pain. Substance P may contrib-
ute to itch by increasing neuronal sensiti-
zationandmayaffectreleaseofmastcells,
which contain many granules rich in his-
tamine, during long-term interaction (2).
In those with diabetes, there is a deﬁ-
ciency of NGF and the response to sub-
stance P is impaired; again, one is
surprised that truncal itching occurs in
diabetic polyneuropathy.
Central sensitization
Noxiousinputtothespinalcordisknown
to produce central sensitization, which
consists of allodynia, exaggeration of
pain, and punctate hyperalgesia, which is
extreme sensitivity to pain. Two types of
mechanical hyperalgesia can occur: 1)
touch that is normally painless in the un-
injured surroundings of a cut or tear can
trigger painful sensations (touch-evoked
hyperalgesia)and2)aslightlypainfulpin-
prick stimulation is perceived as more
painful around a focused area of inﬂam-
mation (punctate hyperalgesia). Touch-
evoked hyperalgesia requires continuous
ﬁringofprimaryafferentnociceptors,and
punctate hyperalgesia does not require
continuous ﬁring, which means it can
persistforhoursafteratraumaandcanbe
stronger than normally experienced. In
addition, it was found that in patients
with neuropathic pain, histamine iono-
phoresis resulted in a sensation of burn-
ing pain rather than itch, which would be
induced in normal healthy patients. This
shows that there is spinal hypersensitivity
to C-ﬁber input in chronic pain (2). Per-
haps the damage to C-ﬁber in small ﬁber
neuropathies (5) unbridles the central
pruritogenic mechanism causing itching.
Thus, although truncal pruritus may
have drawn attention to a possible rela-
tionship with diabetic polyneuropathy,
this is only scratching the surface of the
complex relationship between itching
and central and peripheral somatic and
autonomic nerve function. The provoca-
tive article in this issue of Diabetes Care
should lead to an interesting probing of
the complexities and depths of itching
and provide new insights into the rela-
tionship between peripheral and central
processing of cognitive function in
diabetes.
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